Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

DEXCOM, INC.

(DXCM)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/13/2021 01/14/2021 01/15/2021 01/19/2021 01/20/2021 Date
362.55(c) 352.08(c) 354.2(c) 357.64(c) 364.12 Last
986 825 890 619 752 952 794 548 1 162 819 Volume
+0.66% -2.89% +0.60% +0.97% +1.81% Change
More quotes
Financials (USD)
Sales 2020 1 913 M - -
Net income 2020 218 M - -
Net Debt 2020 24,3 M - -
P/E ratio 2020 159x
Yield 2020 -
Sales 2021 2 331 M - -
Net income 2021 302 M - -
Net cash position 2021 328 M - -
P/E ratio 2021 118x
Yield 2021 -
Capitalization 34 343 M 34 343 M -
EV / Sales 2020 18,0x
EV / Sales 2021 14,6x
Nbr of Employees 3 900
Free-Float 98,8%
More Financials
Company
DexCom, Inc. specialises in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 78.7% of net sales. 
More about the company
Notations Surperformance© of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about DEXCOM, INC.
01/19DEXCOM SCHEDULES FOURTH QUARTER AND : 30 p.m. Eastern Time
BU
01/15DEXCOM : Insider Selling in Dexcom (DXCM) Shares Continues
MT
01/14INSIDER TRENDS : Insider Prolongs 90-Day Selling Trend at Dexcom
MT
01/11DEXCOM : Guides Q4, 2020 Revenue Above Analysts' Estimates; 2021 Revenue In Line..
MT
01/11DEXCOM INC : Results of Operations and Financial Condition, Financial Statements..
AQ
01/11DEXCOM : Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fisca..
BU
01/07INSIDER TRENDS : Insider 90-Day Selling Trend Extended at Dexcom
MT
01/06DEXCOM : UBS Raises DexCom to Buy From Neutral, PT to $445 From $410, Citing Pha..
MT
01/05DEXCOM : to Present at 39th Annual J.P. Morgan Healthcare Conference
BU
2020INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at Dexcom
MT
2020INSIDER TRENDS : Dexcom Insider Continues 90-Day Selling Trend
MT
2020Equities End Mixed as Concerns Over New Coronavirus Strain Take Focus From Pa..
MT
2020INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at Dexcom
MT
2020DEXCOM : Morgan Stanley Adjusts DexCom PT to $402 From $398, Maintains Equal Wei..
MT
2020DEXCOM INC : Change in Directors or Principal Officers (form 8-K)
AQ
More news
News in other languages on DEXCOM, INC.
2020DEXCOM : Le système Dexcom G6 de mesure en continu du glucose bientôt remboursé ..
2020DEXCOM, INC. : publication des résultats trimestriels
2020DEXCOM, INC. : Veröffentlichung des Quartalsergebnisses
2020DEXCOM, INC. : publication des résultats semestriels
2020DEXCOM, INC. : Veröffentlichung des Halbjahresergebnisses
More news
Analyst Recommendations on DEXCOM, INC.
More recommendations
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | MarketScreener
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Average target price 447,17 $
Last Close Price 357,64 $
Spread / Highest target 51,0%
Spread / Average Target 25,0%
Spread / Lowest Target -32,9%
EPS Revisions
Managers and Directors
NameTitle
Kevin Ronald Sayer Chairman, President & Chief Executive Officer
Quentin S. Blackford Chief Operating & Financial Officer
Andrew K. Balo EVP-Clinical Affairs, Regulatory Strategies
Jacob Leach Chief Technology Officer & Executive VP
Shelly R. Selvaraj Senior Vice President-Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.-3.27%34 343
ABBOTT LABORATORIES2.81%192 878
MEDTRONIC PLC1.00%159 248
BECTON, DICKINSON AND COMPANY4.22%75 845
HOYA CORPORATION-5.12%49 012
ALIGN TECHNOLOGY, INC.4.31%43 952